台股 » 個股 » 中化生 » 籌碼相關 » 券商分點績效

中化生

(1762)
可現股當沖
  • 股價
    44.90
  • 漲跌
    --
  • 漲幅
    0.00%
  • 成交量
    149
  • 產業
    上市 生技醫療類股
  • 253人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
中化生 (1762)籌碼相關-券商分點績效/獲利分析
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

«前一日     2024/03/29     後一日»

券商獲利排行 - 2024/03/29

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  8.49%263.5-0.9264.5-6126349.349.749.244.9
  8.72%145.70145.7-3403449.2049.244.9
  8.67%132.20132.2-3103149.2049.244.9
  8.43%111.60111.6-260274949.14944.9
  8.37%98.4098.4-2302449504944.9
  8.13%95.70.195.7-2312449.14949.144.9
  5.32%89.1-1.690.8-21133449.349.449.244.9
  9.29%69069-1501549.5049.544.9
  8.02%66.5066.5-1701748.8048.844.9
  8.37%65.6065.6-160164904944.9
  8.01%54.7054.7-1401448.8048.844.9
  8.52%50.1050.1-1201249.1049.144.9
  9.29%46046-1001049.5049.544.9
  8.73%43.30.842.4-911049.548.849.644.9
  8.63%25.4025.4-60649.1049.144.9
  7.99%23.4023.4-50648.849.848.844.9
  8.74%21.5021.5-50549.2049.244.9
  8.09%15.8015.8-40448.9048.944.9
  9.32%13.8013.8-30349.5049.544.9
  9.11%13.5013.5-30349.4049.444.9
  8.09%11.8011.8-30348.9048.944.9
  7.96%11.6011.6-30348.8048.844.9
  8.55%8.408.4-20249.1049.144.9
  8.18%808-20248.9048.944.9
  8.09%7.907.9-20248.9048.944.9
  8.09%7.907.9-20248.9048.944.9
  7.99%7.807.8-10248.84948.844.9
  9.29%4.604.6-10149.5049.544.9
  8.74%4.304.3-10149.2049.244.9
  8.74%4.304.3-10149.2049.244.9
  8.74%4.304.3-10149.2049.244.9
  8.74%4.304.3-10149.2049.244.9
  8.54%4.204.200149.249.549.144.9
  8.23%404-10148.9048.944.9
  8.09%3.903.9-10148.9048.944.9
  7.90%3.803.8-10148.8048.844.9
   00000049.749.7044.9
   00000049.349.3044.9
   00000049.249.2044.9
   0000005005044.9
   0000004904944.9
   0000004904944.9
   00000049.2049.244.9
   0000005005044.9
   0000004904944.9
   000000494949.444.9
   00000049.2049.244.9
   00000049.349.3044.9
   00000049.3049.344.9
   0000005005044.9

券商虧損排行 - 2024/03/29

券商分點績效總損益(仟)己實現(仟)未實現(仟)買賣超買張賣張均價均買均賣現價
  -8.83%-82.60-82.61919049.349.3044.9
  -8.59%-54.80-54.81313049.149.1044.9
  -8.62%-50.80-50.81212049.149.1044.9
  -8.58%-50.50-50.51212049.149.1044.9
  -8.37%-49.20-49.2121204949044.9
  -8.83%-43.50-43.51010049.249.2044.9
  -7.99%-390-391010048.848.8044.9
  -9.89%-34.50-34.577049.849.8044.9
  -8.53%-29.30-29.377049.149.1044.9
  -9.11%-270-2766049.449.4044.9
  -8.86%-26.20-26.266049.349.3044.9
  -8.85%-26.10-26.166049.349.3044.9
  -8.55%-25.20-25.256049.149.149.444.9
  -8.30%-24.40-24.46604949044.9
  -8.92%-220-2255049.349.3044.9
  -8.40%-20.60-20.65504949044.9
  -8.03%-19.60-19.645048.848.849.344.9
  -9.02%-17.80-17.844049.449.4044.9
  -8.81%-17.30-17.344049.249.2044.9
  -8.80%-17.30-17.344049.249.2044.9
  -8.71%-17.10-17.144049.249.2044.9
  -8.56%-16.80-16.844049.149.1044.9
  -4.84%-16.70.3-1737349.249.249.344.9
  -8.41%-16.50-16.54404949044.9
  -8.25%-16.10-16.144048.948.949.244.9
  -8.18%-160-1644048.948.9044.9
  -8.09%-15.80-15.844048.948.9044.9
  -5.83%-14.3-1-13.335249.249.448.944.9
  -9.38%-13.90-13.933049.649.6044.9
  -9.38%-13.90-13.933049.549.5044.9
  -8.89%-13.10-13.133049.349.3044.9
  -8.67%-12.80-12.833049.249.2044.9
  -6.39%-12.5-0.2-12.4341494948.944.9
  -8.49%-12.50-12.533049.149.1044.9
  -8.46%-12.40-12.433049.149.1044.9
  -8.31%-12.20-12.23304949044.9
  -8.27%-12.10-12.13304949044.9
  -8.09%-11.90-11.933048.948.9044.9
  -8.09%-11.80-11.833048.948.9044.9
  -9.34%-9.20-9.222049.549.5044.9
  -9.20%-9.10-9.122049.549.5044.9
  -9.02%-8.90-8.922049.449.4044.9
  -8.88%-8.70-8.722049.349.3044.9
  -8.84%-8.70-8.722049.349.3044.9
  -8.74%-8.60-8.622049.249.2044.9
  -8.74%-8.60-8.622049.249.2044.9
  -8.60%-8.40-8.422049.149.1044.9
  -8.60%-8.40-8.422049.149.1044.9
  -8.55%-8.40-8.422049.149.1044.9
  -8.55%-8.40-8.422049.149.1044.9
中化生魚油原料藥產能倍增最快年底過美認證 明年營收再登高Anue鉅亨-2022/11/14
年度傑出生技產業獎 中化生、藥華藥入列Anue鉅亨-2022/07/22
〈中國限電〉中印限電危機原料藥再度供給失衡 中化生、台耀迎轉單潮Anue鉅亨-2021/10/07
中化生 相關文章